Nantahala Capital Management, LLC is 10% at Sucampo Pharmaceuticals, Inc. (SCMP). They have made 1 open-market trade across 1 company since 2012, most recently 2020-11-12.
CIK 0001472322
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2020, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCMP | SELL | 2012-04-23 | 2012-04-24 | $8.25 | $1.8M | -21.8% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.